Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 1,733
- Locations
- 2
- Primary Endpoint
- Bleeding
Study Overview
Brief Summary
The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb joint replacement, the influence of known risk factors and strategies for perioperative prevention of thromboembolic complications on the frequency of cardiovascular complications and to develop approaches to optimize antithrombotic prevention tactics.
Study Design
- Study Type
- Observational
- Observational Model
- Ecologic Or Community
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 95 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Informed consent
- •Age older than 18 y.o.
- •Cardiovascular disease
- •Indications for planned lower limb joint replacement surgery
Exclusion Criteria
- •Pregnancy
- •Psychiatric disorders
- •Decompensated heart failure or acute heart failure
- •Known diagnosis of cancer
Outcomes
Primary Outcomes
Bleeding
Time Frame: 6 months
All the cases of major and minor bleeding within 6 months
Thromboembolism
Time Frame: 6 months
All the cases of venous thromboembolism within 6 months
Secondary Outcomes
No secondary outcomes reported
Investigators
Olga Trushina
Professor
I.M. Sechenov First Moscow State Medical University
